National Health Act (Pharmaceutical Benefits Early Supply) Amendment March 2013 specification under subsection 84AAA(2) (No. PB 13 of 2013) (Cth)
COMMONWEALTH OF AUSTRALIA
Instrument number PB 13 of 2013
National Health Act (Pharmaceutical Benefits – Early Supply) Amendment March 2013 - specification under subsection 84AAA(2)1
Amendment determination under subsection 84AAA(2) of the National Health Act 1953
I, Adriana Platona, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.
Dated 21 February 2013
ADRIANA PLATONA
Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment determination — Pharmaceutical Benefits - Early Supply
1 Name of Instrument
(1) This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment March 2013 - specification under subsection 84AAA(2).
(2) This Instrument may also be cited as No. PB 13 of 2013.
2 Commencement
This Determination commences on the later of the following:
(a) 1 March 2013;
(b) the day after it is registered.
3 Amendment of PB 30 of 2009
Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009- specification under subsection 84AAA(2), PB 30 of 2009.
Schedule 1 Amendments
Schedule 1, after entry for Testosterone in the form Transdermal patches 24.3 mg, 30
insert in the columns in the order indicated:
| Transdermal solution (pump pack) 30 mg per 1.5 mL dose, 60 doses | Transdermal | 1 Pack | 5 |
1Note
All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.
See
0
0
0